Pathogenesis and treatment of craniopharyngioma-related liver diseases
- VernacularTitle:颅咽管瘤相关肝脏疾病的致病机制及治疗
- Author:
Ye CHENG
1
;
Yin ZHENG
1
;
Jie QIN
1
Author Information
- Publication Type:Review
- Keywords: Craniopharyngioma; Metabolic Dysfunction-Associated Fatty Liver Disease; Hypothalamic Diseases; Growth Hormone; Therapeutics
- From: Journal of Clinical Hepatology 2026;42(8):1974-1979
- CountryChina
- Language:Chinese
- Abstract: Patients with craniopharyngioma are at a high risk of developing metabolic dysfunction-associated fatty liver disease and its severe complications， yet this association is often neglected in clinical practice， with a lack of systematic reviews. This article systematically reviews the clinical spectrum and epidemiological characteristics of liver diseases associated with craniopharyngioma， with a focus on their core pathogenic mechanisms， and it also summarizes current tumor treatment strategies aimed at preventing hypothalamic injury and highlights that establishing a multidisciplinary collaborative diagnosis and treatment model and implementing early intervention are key to improving prognosis. Future research should focus on elucidating the precise pathways through which hypothalamic injury leads to metabolic disturbances， thereby facilitating the development of targeted therapies， in order to provide new directions for fundamentally improving the clinical outcomes of these patients.
